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Regulation by C5a of Neutrophil Activation
during Sepsis
al., 1997), which appears to be a prerequisite for TNF
production (Jin et al., 1997).
Recently published data provide compelling evidence
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Thomas A. Neff, Hongwei Gao, Cecilia Speyer,
Vidya J. Sarma, Firas S. Zetoune, and Peter A. Ward* for the beneficial effects of blockade of either C5a or
C5a receptor (C5aR, CD88) in experimental sepsis (Czer-Department of Pathology
University of Michigan Medical School mak et al., 1999; Huber-Lang et al., 2001b; Riedemann
et al., 2002b). In humans, C5a has been described as aAnn Arbor, Michigan 48109
serum marker that correlates with the severity of sepsis
(Nakae et al., 1994). Compromised innate immune func-
tions (H2O2 production, chemotaxis, and phagocytosis)Summary
of neutrophils during CLP-induced sepsis are restored
in rodents undergoing blockade of C5a (Huber-Lang etIn sepsis, there is evidence that excessive C5a genera-
tion leads to compromised innate immune functions, al., 2001a; , 2002). It has been suggested that C5a might
be responsible for compromised neutrophil functionbeing associated with poor outcome. We now report
that in vitro exposure of neutrophils to C5a causes during human sepsis (Solomkin et al., 1981). Recent
studies in CLP rodents confirm the deleterious effectsincreased levels of IB, decreased NF-B-dependent
gene transcription of TNF, and decreased lipopoly- of C5a on neutrophil function (Huber-Lang et al., 2002).
To date, there is little knowledge about direct effects ofsaccharide (LPS)-induced TNF production. Similar
findings were obtained with neutrophils from cecal C5a on neutrophil production of cytokines. We investi-
gated the effects of C5a on LPS-induced TNF produc-ligation/puncture (CLP)-induced septic rats. Such
changes were reversed by antibody-induced in vivo tion in neutrophils from normal and CLP rats. The data
suggest a previously unrecognized inhibitory functionblockade of C5a. In contrast, in vitro exposure of alveo-
lar macrophages to C5a and LPS resulted in enhanced of C5a for LPS-induced TNF production specifically in
neutrophils but not in macrophages.production of TNF and no increase in IB. These
data suggest that CLP-induced sepsis causes a C5a-
dependent dysfunction of neutrophils, which is char- Results
acterized by altered signaling associated with NF-B
activation. Effects of C5a on LPS-Induced TNF Production
in Neutrophils
Introduction We recently found that C5a has a synergistic effect on
TNF production in primary cultures of rat alveolar epi-
Complement activation plays a key role in innate im- thelial cells that were costimulated with LPS in vitro
mune defenses against invading bacteria. Through the (Riedemann et al., 2002c). To define the effects of C5a on
opsonic function of C3b, phagocytosis and intracellular LPS-induced production of TNF in neutrophils, blood
killing of bacteria are facilitated (Wilkinson et al., 1979). neutrophils were obtained from normal rats and incu-
During the onset of sepsis, there is accumulating evi- bated with LPSC5a. Unexpectedly, 10 nM C5a exerted a
dence for excessive production of the anaphylatoxin, significant inhibitory effect (73%) on LPS-induced TNF
C5a, in rodents and in humans (de Boer et al., 1993; production in neutrophils (Figure 1A). RT-PCR analysis
Smedegard et al., 1989). C5a is known to exert numerous of isolated total RNA from LPS-stimulated neutrophils
proinflammatory effects such as chemotactic responses in the presence or absence of C5a revealed that the
of neutrophils (Shin et al., 1968), release of granular findings in Figure 1A were due to transcriptional regula-
enzymes from phagocytic cells (Goldstein and Weiss- tion, since C5a caused decreased gene transcription
mann, 1974), production by neutrophils of superoxide for TNF in the presence of LPS (Figure 1B). ELISA
anion (Sacks et al., 1978), vasodilatation, increased vas- measurements of TNF in whole cell lysates of neutro-
cular permeability (Schumacher et al., 1991), and induc- phils showed a reduced level of TNF after treatment
tion of thymocyte apoptosis during sepsis (Guo et al., with LPS in the copresence of C5a when compared to
2000; Riedemann et al., 2002a). cells only stimulated with LPS (p  0.05) (Figure 1C).
TNF is a proinflammatory mediator thought to play These data are consistent with the data in frame 1B in
an important role during the onset of sepsis (Tracey et which the copresence of C5a reduced the amount of
al., 1986). Neutrophils appear to be a major source of TNF mRNA after addition of LPS, suggesting that the
TNF in response to inflammatory stimuli such as LPS reduced TNF content in neutrophil supernatant fluids
(Dubravec et al., 1990). TNF blockade with antibodies (Figure 1A) was due to reduced transcriptional expres-
has been associated with improved survival of baboons sion of TNF.
challenged with live bacteria (E. coli) (Tracey et al., 1987)
and mice challenged with LPS (Beutler et al., 1985). In Selectivity of C5a Induced Inhibition of TNF
neutrophils, LPS induces NFB activation (McDonald et Production and NF-B Dependency of TNF
Production in Neutrophils
To investigate the selectivity of the observed effects of*Correspondence: pward@umich.edu
1These authors contributed equally to this work. C5a on LPS-induced TNF production in neutrophils,
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Figure 1. Effects of C5a on LPS-Induced
TNF Production in Neutrophils
(A) ELISA measurements for TNF in super-
natant fluids from neutrophils (2  106 cells/
ml) after in vitro incubation for 4 hr at 37C
with C5a (10 nM) or LPS (20 ng/ml). Data are
representative of four independent experi-
ments. Neutrophils were pooled from six to
eight animals per study; incubation and anal-
ysis were carried out in separate quadrupli-
cate samples.
(B) RT-PCR results for TNF mRNA and re-
lated densitometry analysis using neutrophils
that were treated as indicated. Equal loading
of RNA was demonstrated with DNA bands
for GAPDH. Total RNA was isolated after 2 hr
of in vitro incubation as depicted, with the
same concentrations of additives used for ex-
periments in frame A. Data are representative
for two independent experiments with neu-
trophils pooled from eight rats per study.
(C) ELISA analysis for TNF content in cell
lysates from rat neutrophils. Neutrophils were
treated as described in (A). Data are repre-
sentative for neutrophils from three animals
per condition, with samples done in quadru-
plicate. The symbol (*) marks statistical signif-
icant difference from the LPS-only stimulated
groups in (A) and (C).
we conducted in vitro experiments with blood neutro- phils. Figure 2B demonstrates that 100g/ml IC resulted
in a robust TNF production in PMN. Costimulation withphils from healthy rats, in which C5a was replaced by
N-formyl-Met-Leu-Phe (fMLP) as another agonist for a C5a did not alter this response. At 10 g/ml IC, costim-
ulation with C5a resulted in a slight reduction of TNFG protein coupled receptor. As demonstrated in Figure
2A, fMLP (10–100 nM) had marginal effects on LPS- production, but this reduction was significantly less than
the C5a-induced reduction of LPS-induced TNF gener-induced TNF production. The reduction was signifi-
cantly less than that, caused by C5a (used at a concen- ation (Figure 2A). These data suggest that C5a may be
unique in suppressing the LPS-induced production oftration of 10 nM). These data suggest that the observed
C5a effect (Figure 1) is highly specific, when compared TNF in neutrophils when compared to C5a effects on
FC-receptor signaling (IC)-induced TNF generation into another G protein employing stimulus like fMLP.
We used as another stimulus in vitro generated IgG neutrophils or when compared to the effects of fMLP
on LPS-induced TNF generation.immune complexes (IC) to investigate the potential of
C5a to reduce IC-induced generation of TNF in neutro- In order to determine if TNF generation in neutrophils
C5a and Neutrophil Dysfunction during Sepsis
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Figure 3. Effects of C5a on LPS-Induced TNF Production in Neu-
trophils during Sepsis
(A) Blood neutrophils were isolated at various time points after CLP
and stimulated in vitro for 4 hr with LPS (20 ng/ml). The data are
representative of experiments conducted with pooled neutrophils
from 4–6 rats per condition and in vitro stimulation conducted in
separate quadruplicates.
(B) Neutrophils were isolated separately from four rats per time point
at 0 hr, 6 hr, and 7 days after CLP and cells were treated, as indicated,
for in vitro stimulation before lysis and ELISA analysis of cell lysates
for TNF.
was NF-B dependent, we conducted in vitro experi-
ments (similar to those in Figure 1), using neutrophils
exposed to Bay11-7082, a potent and irreversible inhibi-
tor of IB phosphorylation and NF-B activation. As
demonstrated in Figure 2C, inhibition of NF-B activa-
tion resulted in complete abolition of TNF production
in LPS-stimulated neutrophils. These data confirmed
that TNF generation in neutrophils is dependent on
NF-B activation.
TNF Production in Blood Neutrophils during Sepsis
Figure 2. Selectivity and NF-B Dependency of C5a-Induced Inhibi-
After the onset of sepsis in CLP rats, blood neutrophilstion of TNF Production in Neutrophils
were isolated at various time points (1–12 hr and 7 days)
(A, B, and C) ELISA measurements for TNF in supernatant fluids
to investigate their ability to respond in vitro to LPSfrom neutrophils (2  106 cells/ml) after in vitro incubation for 4 hr
with TNF production. In dramatic contrast to TNFat 37C with C5a (10 nM) or LPS (20 ng/ml). (A) Effect of fMLP on
LPS-induced TNF production in neutrophils. (B) Effect of C5a on production in LPS-stimulated neutrophils from control
immune complex (IC) induced TNF production in PMN. (C) Effect donors (time 0), TNF production in neutrophils from
of preincubation with Bay 11-7082 (NF-B inhibitor) on LPS-induced CLP rats was significantly reduced during the first 12
TNF production in neutrophils. The symbol (*) indicates statistical hr of sepsis, especially at 6 and 12 hr, at which time
significant difference from the LPS-only stimulated groups, and (**)
TNF levels were nearly undetectable (Figure 3A). Inindicates statistical significant difference from the LPS-C5a costi-
such circumstances, TNF production at 12 hr fell by mulated group in (A). Data are representative for two independent
experiments, each carried out with pooled neutrophils from four to 99% when compared to neutrophils from normal rats.
six animals per condition, with samples done in quadruplicates. Neutrophils from 7 day survivors, on the other hand,
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responded more robustly to in vitro LPS stimulation, LPS (20 ng/ml), or the combination of C5a and LPS. The
results shown in Figure 5A indicate the induction of IBwith TNF production similar to the levels produced by
neutrophils from animals very early after CLP (1 hr). protein (analyzed by Western blot analysis) in C5a-
exposed neutrophils. The IB band in untreated neu-ELISA analysis of cell lysates for TNF revealed that the
intracellular content of TNF was reduced at 6 hr after trophils was faint and was clearly increased in C5a-
exposed neutrophils. LPS incubation actually decreasedCLP (but not in a statistically significant manner) when
compared to control neutrophils or neutrophils obtained IB content when compared to control neutrophils. In
conjunction with LPS, C5a magnified the induction offrom 7 day surviving CLP animals (Figure 3B). These data
suggest that the near abolition in LPS-induced TNF IB as compared to the effects of LPS alone. In the
same experimental setting, cellular levels of IB	 re-production in neutrophils obtained 6 and 12 hr after CLP
is likely due to a transcriptional block in TNF produc- mained unaltered (Figure 5A, lower frame).
Additional experiments were undertaken using cyto-tion. Alternatively, this could be due to a significant
defect in signaling pathways required for production solic extracts of blood neutrophils from non-CLP rats
(0 hr) and from rats 6 hr, 24 hr, and 7 days after CLP.and/or secretion of TNF.
As shown in Figure 5B, neutrophils from non-CLP rats
showed little detectable IB content, while, as ex-Effects of C5a Blockade during Sepsis on Serum TNF
pected, in vitro exposure of neutrophils to C5a causedand In Vitro Production of TNF by Neutrophils
induction of IB. Blood neutrophils from 6 hr or 24 hrTo examine during sepsis the possible role of C5a in
CLP animals showed the clear presence of IB, whilethe loss of responsiveness in LPS-induced TNF pro-
in vitro exposure of neutrophils to C5a did not appearduction in neutrophils, we conducted experiments in
to further increase the amount of IB. Seven days afterwhich endogenous C5a appearing during sepsis was
CLP, blood neutrophils showed little, if any, presenceblocked by anti-C5a IgG injected intravenously at the
of IB, while in vitro exposure of these cells to C5astart of CLP. This intervention led to a significantly im-
caused clear induction of IB, a pattern similar to thoseproved LPS-induced TNF response in neutrophils from
found in control (0 hr) neutrophils.6 hr CLP animals when compared to the group of animals
To investigate the role of C5a in induction of IB inthat received an equivalent amount of irrelevant control
neutrophils during sepsis, we conducted experiments inIgG (Figure 4A). To further investigate whether these
which C5a was blocked in vivo in CLP rats with antibodymanipulations had effects on serum TNF content dur-
infused at the start of CLP (Figure 5C). As expected, ining sepsis, we measured TNF levels during sepsis.
neutrophils isolated from animals 6 hr after CLP, IBExperiments with an ultrasensitive TNF ELISA kit re-
was readily detected in neutrophils from CLP ratsvealed in serum a peak in TNF concentrations 6 hr
treated with preimmune IgG. Exposure in vitro of theseafter CLP (Figure 4B). In animals treated with anti-C5a
cells to C5a did not seem to alter the intensity of theIgG at the start of CLP, the TNF serum concentration
IB band. In CLP rats protected in vitro with anti-C5a,was significantly higher (nearly 5-fold) 6 hr after CLP
a faint band for IB could be detected in nonstimulatedwhen compared to the group treated with control IgG
blood neutrophils, while in vitro exposure to C5a caused(Figure 4C). These data suggest that C5a blockade dur-
clear induction of IB. These data suggest that the IBing sepsis results in higher serum levels of TNF and
induction in neutrophils during sepsis is likely caused byincreased in vitro production by neutrophils of TNF
intrinsic generation of C5a during sepsis.after stimulation with LPS.
To investigate the mechanism of the C5a-induced in-To strengthen these observations, ribonuclease pro-
crease of IB in neutrophils, we designed primers fortection assays (RPA) were performed using total RNA
a 281 bp sequence of the rat IB gene and conductedfrom blood neutrophils obtained from 6 hr CLP rats that
RT-PCR experiments with total RNA from neutrophilshad been treated intravenously either with 500 g con-
stimulated identically to those described in Figure 1.trol IgG or 500 g anti-C5a IgG at the start of CLP. The
The results in Figure 5D demonstrate that C5a did notresulting data (Figure 4D) demonstrate that neutrophils
significantly induce IB gene transcription in neutro-from CLP animals treated with anti-C5a showed signifi-
phils. Collectively, the data suggest that C5a-inducedcantly increased gene transcription activity for TNF
IB increase in neutrophils is not driven by transcrip-when compared to neutrophils from animals treated with
tional upregulation and may be due to reduced degrada-irrelevant IgG, suggesting that C5a blockade resulted
tion of IB.in preservation of transcriptional activation of TNF in
neutrophils obtained from CLP rats.
Effects of C5a on LPS-Induced TNF Production
in Alveolar MacrophagesEffects of C5a on Intracellular Content of IB
and Gene Transcription in Neutrophils Macrophages are known to produce substantial
amounts of TNF in response to LPS-induced NFBIt is known that the promotor region for the TNF gene
contains the NFB binding sequence and that neutrophil activation (Jin et al., 1997). To investigate effects of C5a
on LPS-induced TNF production in macrophages, weproduction of TNF is dependent on NFB activation.
To define the possible molecular mechanisms related conducted in vitro experiments with alveolar macro-
phages obtained from healthy rats. We found that C5ato the inhibitory effects of C5a on LPS-induced TNF
production in neutrophils, we investigated changes of per se did not induce TNF production in macrophages,
but in conjunction with LPS there was clearly enhancedIB content in rat neutrophils. Whole cell lysates of rat
neutrophils (1.5 106) were obtained after cell exposure production of TNF (Figure 6A). RT-PCR experiments
with total RNA from alveolar macrophages revealed that(60 min at 37C) to culture medium (ctrl), C5a (10 nM),
C5a and Neutrophil Dysfunction during Sepsis
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Figure 4. Effects of In Vivo Blockade of C5a on LPS-Induced TNF Production in Neutrophils and on Serum Levels of TNF during Sepsis
(A) TNF as measured by ELISA analysis in supernatant fluid from neutrophils isolated 6 hr after CLP and followed by in vitro incubation with
LPS (20 ng/ml). Neutrophils were isolated from animals treated at time 0 of CLP with either preimmune IgG or anti-C5a IgG (500 g, injected
intravenously at time 0) (*, p  0.05).
(B) ELISA analysis of serum TNF levels during CLP-induced sepsis at various time points (n 
 4–6 per time point).
(C) Serum ELISA analysis for TNF at 6 hr after CLP in animals treated with either irrelevant IgG or anti-C5a IgG at the start of CLP, with
significant differences (*, p  0.05) in serum TNF levels (n 
 5 per condition).
(D) Ribonuclease protection assay performed with total RNA from pooled neutrophils from four to six septic rats per condition. Groups were
treated intravenously at time 0 with either 500 g/animal anti-C5a or 500 g/animal irrelevant IgG.
the findings depicted in Figure 5A were also reflected with whole cell lysates from alveolar macrophages, which
had been stimulated in vitro for 2 hr at 37C, similar toat the transcriptional level (Figure 6B). The additive ef-
fect of C5a on LPS-induced TNF production in alveolar the conditions used in Figure 5A. The results demon-
strate that in macrophages C5a had failed to inducemacrophages appeared to be somewhat more prominent
in macrophages obtained from animals at 24 hr after measurable increases in IB and enhanced, rather than
suppressed, LPS-induced production of TNF (FigureCLP (Figure 6C), consistent with the possibility that
these cells had been “primed” in vivo during CLP. Such 6). These data underscore the functionally different ef-
fects of C5a on signaling pathways in neutrophils andresults, together with similar findings in alveolar epithe-
lial cells (Riedemann et al., 2002c), are in striking contrast macrophages.
to the C5a-induced inhibition of neutrophil responses to
LPS (Figures 1 and 3), suggesting a cell-specific inhibi- Discussion
tory role of C5a in neutrophils.
To evaluate the effects of C5a on IB content in Neutrophils are well known to play a major role in de-
fenses against invading bacteria. There is evidence thatmacrophages, we conducted Western blot experiments
Immunity
198
Figure 5. Effects of C5a on IB Content in Neutrophils during Sepsis
(A) Western blot analysis for IB and IB	 in blood neutrophil whole cell lysates. Neutrophils were isolated after 2 hr in vitro incubation with
various stimuli, as depicted.
(B) Western blot analysis for IB in cytoplasmic extracts (40 g protein per lane) from blood neutrophils isolated from animals 0, 6, and 24
hr and 7 days after CLP, and incubated in vitro for 2 hr with no additive (ctrl) or C5a (10 nM).
(C) Western blot analysis of cytoplasmic extracts from blood neutrophils isolated 6 hr after CLP and 2 hr in vitro stimulation as described for
(B). Neutrophils were isolated from animals treated with either irrelevant IgG or anti-C5a IgG at the start of CLP. Data are representative for
two to three independent experiments per figure.
(D) RT-PCR results for IB mRNA using neutrophils that were treated as indicated. Equal loading of RNA was demonstrated with DNA bands
for GAPDH. Total RNA was isolated after 2 hr of in vitro incubation as depicted, with the same concentrations of additives used for experiments
in frame A. Data are representative of two independent experiments with neutrophils pooled from six rats per study.
neutrophils contribute substantially to levels of TNF in very low during sepsis but enhanced by blockade of
C5a during CLP (Figure 4C). It should be noted thatserum during inflammatory responses (Matsumoto et
al., 1997). Recently, accumulating data have provided TNF levels in CLP rats are quite low, with or without
C5a blockade (Figures 4A and 4B). Our data appear to beevidence for a major role of the complement activation
product, C5a, and its receptor (C5aR) in the outcome in in conflict with earlier published results, demonstrating
that high TNF levels are associated with lethality, whensepsis (Czermak et al., 1999; Huber-Lang et al., 2001a,
2001b; Riedemann et al., 2002b). As outlined above, mice or baboons were injected with high doses of LPS
or live E. coli, which provoked very high TNF levels inC5a exerts numerous proinflammatory effects, but in
the case of neutrophils excessive C5a production during the serum (Beutler et al., 1985; Tracey et al., 1987). In
fact, serum TNF levels found after LPS infusion intosepsis seems to inhibit crucial innate immune functions
of neutrophils, including phagocytosis, chemotaxis, and mice were shown to be more than 200-fold higher than
in CLP animals (Eskandari et al., 1992), or than TNFH2O2 production (Huber-Lang et al., 2002). In the current
study we sought to investigate the effects of C5a on levels found in human sepsis. CLP mice treated with
anti-TNF antibodies did not show improved survivalfunctional responses of neutrophils, focusing on pro-
duction of TNF after stimulation by LPS. C5a had signif- but, rather, a tendency for worsened outcomes (Eskan-
dari et al., 1992). We interpret these data to suggest thaticant inhibitory effects on LPS-induced production of
TNF in neutrophils, which was in striking contrast to CLP-induced sepsis causes moderately elevated levels
of TNF, which may serve as protective mediator underthe results obtained in macrophages in which C5a en-
hanced TNF production. Suppression of TNF produc- such conditions and that, in the case of neutrophils,
TNF production represents an important innate im-tion in neutrophils was regulated at the transcriptional
level. In vivo blockade of C5a with antibodies signifi- mune response.
We demonstrate in this study that neutrophils fromcantly restored the responsiveness of neutrophils from
CLP animals for LPS-induced TNF production in vitro septic animals responded to LPS stimulation with dimin-
ished generation of TNF, when compared to neutro-(Figure 4A). This effect was also reflected at the systemic
level, namely, TNF serum concentrations, which were phils from healthy animals or neutrophils from CLP rats
C5a and Neutrophil Dysfunction during Sepsis
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Figure 6. Effect of C5a on LPS-Induced TNF and IB Production in Alveolar Macrophages
(A) ELISA results in supernatant fluids from AM from healthy rats after in vitro incubation for 4 hr at 37C with C5a (10 nM) or LPS (20 ng/ml),
or the combination.
(B) RT-PCR results for TNF mRNA in AM and densitometry analysis, as a function of in vitro conditions. Equal loading was demonstrated
with DNA bands for GAPDH. Total RNA was isolated after 2 hr of in vitro incubation as depicted with the same concentrations used for
experiments in (A). Data are representative for two independent experiments with AM pooled from eight rats per study.
(C) ELISA results in supernatant fluids from AM obtained from rats 24 hr after CLP and followed by in vitro incubation for 4 hr with C5a (10
nM) or LPS (20 ng/ml), or the combination, as depicted. Data are representative of two independent experiments with AM pooled from six to
eight animals per study, with incubation and analysis being carried out in separate quadruplicate samples. The symbol (*) marks statistical
significant difference from the LPS-only stimulated groups in (A) and (C).
(D) Western blot analysis for IB in whole cell lysates of alveolar macrophages. Macrophages were lysed after 2 hr in vitro incubation with
various stimuli, as depicted, with identical concentrations as described in (A). Data are representative for two independent experiments with
macrophages pooled from three rats per experiment.
treated with anti-C5a. While the tachyphylactic effects nuclear translocation of NFB (McDonald et al., 1997).
Blockade of IB degradation occurs with secretoryof LPS are well documented in vitro, CLP-induced sepsis
in rodents does not induce substantial increase of LPS leukoprotease inhibitor (SLPI), which inhibits LPS-
induced NFB activation and TNF production (Taggartlevels in the serum (Newcomb et al., 1998). It is therefore
questionable whether CLP induces the presence of et al., 2002). Our experiments indicate that C5a induces
elevated levels of IB in neutrophils in a non-transcrip-enough LPS in the serum to reduce the responsiveness
of neutrophils to LPS. While LPS may play a role in CLP, tional-dependent manner (Figure 5), causing greatly re-
duced LPS-induced gene transcription and expressionit seems more likely that other mediators, such as C5a,
are more importantly involved in compromising innate of TNF (Figure 1B). During sepsis, increased levels of
IB appeared in blood neutrophils and in vivo blockadeimmune functions.
In human neutrophils, LPS is known to induce TNF of C5a at the start of sepsis largely suppressed the
buildup in neutrophils of IB (Figure 5C). In turn, in vivoproduction by activating various kinases such as p-38
mitogen activated kinase (p38 MAP kinase) and others blockade of C5a during CLP restored the ability of C5a
to induce IB in vitro in neutrophils obtained from CLP(Nick et al., 1999), leading to NFB activation (McDonald
et al., 1997). In this process, IB degradation has been animals (Figure 5C). There is accumulating evidence in
the literature for the appearance of significant levels ofconsidered to be crucial in permitting activation and
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solution (DPBS) immediately after CLP. Control animals receivedC5a (10–100 nM) in the serum early during the onset of
similar amounts of IgG antibody.sepsis. Therefore, during sepsis C5a may be an impor-
tant mediator responsible for neutrophil buildup of IB,
Neutrophil Isolation and In Vitro Stimulation
which interferes with neutrophil responsiveness. IB Whole blood from rats was drawn from the inferior vena cava. Citrate
induction in neutrophils is likely to affect many functions, was used as an anti-coagulant (ACD from Baxter Health Care, Mun-
interfering with several NFB-dependent signaling path- delein, IL). Neutrophils were isolated using Ficoll-Paque gradient
centrifugation (Pharmacia Biotech, Uppsula, Sweden) and dextranways and related gene transcription events.
sedimentation. Red blood cell lysis was achieved, using NH4Cl lysisFinally, we provide evidence that the observed inhibi-
buffer. PMN were resuspended in Dulbecco’s Modified Eagle Me-tory effects of C5a on LPS-induced TNF production
dium (DMEM) (BioWhittaker Inc., Walkersville, MD) containing 5%
and gene transcription are neutrophil-selective effects, serum. A final concentration of 2 106 cells/ml was used for stimula-
since we found the opposite effects in macrophages tion at 37C for 2–4 hr. Supernatants were collected after pelleting
(Figure 6). The latter findings are similar to the ability of the cells and frozen at -80C until used for ELISA analysis. For
certain experiments, neutrophils were preincubated with 20 M ofof C5a to enhance mediator release in LPS-stimulated
the NF-B activation inhibitor Bay 11-7082 (Calbiochem, San Diego,alveolar epithelial cells (Riedemann et al., 2002c). It has
CA) for 30 min prior to stimulation.been reported that the composition of the various com-
ponents of the NFB complex in neutrophils differs from
Isolation of Alveolar Macrophages
those found in macrophages (McDonald et al., 1998). Alveolar macrophages from rats were isolated immediately after
This may explain the observed differences of C5a effects sacrificing the animal. After cannulating the trachea and fixation of
on LPS-induced TNF production in neutrophils and the catheter, bronchoalveolar lavage (BAL) was performed with 10
ml ice cold Dulbecco’s buffered saline solution (DPBS) five times.macrophages. The current understanding of the role
BAL fluids were centrifuged at 1600 rpm and alveolar macrophagesof IB in inhibition of NFB activation has changed
were resuspended in DMEM containing 5% serum. A final concen-significantly in recent years (Li and Verma, 2002). In
tration of 2  106 cells/ml was used for stimulation at 37C for 4 hr.
monocytes, NFB activation occurs within 15 min after Supernatants were treated similarly to those from neutrophils.
stimulation with C5a (Pan, 1998). NFB activation after
stimulation with C5a in neutrophils has not been re- Collection of Serum Samples from Septic Animals
After induction of sepsis, animals were sacrificed at various timeported. The current data suggest substantial differences
points after CLP and blood was drawn from the inferior caval vein.between the two phagocytic cell types, at least with
Blood samples were allowed to clot on ice for 4 hr before centrifuga-respect to the effects of C5a.
tion at 4000 rpm for 15 min at 4C. Serum was collected and immedi-Taken together, our data suggest a previously unrec-
ately frozen at -80C until used for ELISA analysis.
ognized cell-specific inhibitory role of C5a for innate
immune functional responses of neutrophils during sep- Quantitation of TNF by ELISA
sis. These data provide further evidence for the harmful TNF levels of supernatants from rat neutrophils or macrophages
were determined using an ELISA kit for rat TNF (Biosource Intl.effects of excessive in vivo generation of C5a. Under-
Inc., Camarillo CA), according to the manufacturer’s instructions.standing the underlying mechanisms leading to im-
Various dilutions for supernatant fluids from LPS and LPS  C5apaired neutrophil function during sepsis may be a crucial
stimulated neutrophils were analyzed.
step for the development of new therapeutic targets for
treatment of sepsis. Western Blot Analysis
Neutrophils were isolated from normal or CLP animals and stimu-
Experimental Procedures lated at 37C in vitro with C5a (10 nM) or lipopolysaccharide (LPS,
20 ng/ml), or both. Approximately 1.5  106 cells per condition
Production of Anti-C5a Antibody were then used for whole cell lysate experiments. Cytoplasmic and
The C-terminal end of the rat C5a molecule (sequence: CTIADKIRK nuclear fractions were obtained, using a kit (Pierce Inc., Rockford,
ESHHKGMLLGR) corresponding to the amino acids 58-77 was cho- IL). Lysates were separated on a NuPAGE 12% Bis-Tris gel (In-
sen for peptide synthesis, as described previously (Huber-Lang et vitrogen, Carlsbad, CA) and proteins then transferred to a PVDF
al., 2001b). The peptide was coupled to keyhole limpet hemocyanin membrane. Membranes were incubated overnight with antibodies
and then used for the immunization of goats and the production of to IB and IB	 (Santa Cruz Biotechnology Inc., Santa Cruz, CA).
anti-sera. The anti-peptide-specific antibody was affinity purified. Its For detection of the protein, enhanced chemoluminescence (ECL)
crossreactivity with recombinant rat C5a was confirmed in Western was used (Amersham Pharmacia Biotech Inc., Piscataway, NJ) ac-
blots. cording to the manufacturer’s instructions.
Cloning and Expression of Rat C5a RT-PCR Analysis for TNF and IB Gene Transcription
Recombinant rat C5a was produced in our laboratory, using the Neutrophils and alveolar macrophages were isolated and stimulated
pGEX expression vector for GST gene fusion (Amersham Pharmacia in vitro with either C5a (10 nM), LPS (20 ng/ml), or LPS  C5a.
Biotech, NJ) (Guo et al., 2000). Total RNA was isolated from approximately 20–30  106 cells per
condition using the Trizol method (Life Technologies Inc., Rockville,
MD). Digestion of any contaminating DNA was achieved by treat-Experimental CLP-Induced Sepsis
Specific, pathogen-free 300 g male Long Evans rats (Jackson Labo- ment of samples with RQ1 Rnase-free DNase (Promega, Inc., Madi-
son, WI). Reverse transcription was performed with 5 g RNA, usingratories, Bar Harbor, ME) were used for all studies. Anesthesia was
achieved by intraperitoneal injection of Ketamine. In the CLP model, the Superscript II RNase H– Reverse Transcriptase (Gibco BRL, Inc.,
Grand Island, NY). PCR was performed using primers, which de-approximately 1/3 of the cecum was ligated through a 3 cm abdomi-
nal midline incision. The ligated part of the cecum was punctured tected a 465 bp section of the rat TNF gene (Biosource Intl. Inc.,
Camarillo, CA). Primers for detection of the “housekeeping” genethrough and through with a 21 gauge needle. After repositioning of
the bowel, the abdomen was closed in layers, using a 4.0 surgical GAPDH were: 5 primer, 5-GCC TCG TCT CAT AGA CAA GAT G-3
and 3 primer, 5-CAG TAG ACT CCA CGA CAT AC-3. Primers forsuture (Ethicon Inc., Somerville, NJ) and metallic clips. Sham animals
underwent the same procedure without ligation or puncture of the detection of IB gene transcription were designed for a 281 bp
sequence of the rat IB gene and designed as follows: 5 primer,cecum. Where indicated, animals received intravenously 500 g
anti-C5a antibody in 500 l Dulbecco’s phosphate buffered saline 5-CTT TGC AAG CTG AGA CTG AG-3 and 3 primer, 5-GTA ACC
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TAC CAG GGC TAC TC-3. The RT-PCR product was confirmed by Younger, J.G., et al. (2001b). Protective effects of anti-C5a peptide
antibodies in experimental sepsis. FASEB J. 15, 568–570.electrophoresis of samples in 1.2% agarose gel. Control experi-
ments were performed in which reverse transcriptase was not added Huber-Lang, M.S., Younkin, E.M., Sarma, J.V., McGuire, S.R., Lu,
to the samples in order to rule out contaminating DNA being respon- K.T., Guo, R.F., Padgaonkar, V.A., Curnutte, J.T., Erickson, R., and
sible for any results. Ward, P.A. (2002). Complement-induced impairment of innate immu-
nity during sepsis. J. Immunol. 169, 3223–3231.
Multiprobe Ribonuclease Protection Assay Jin, F.Y., Nathan, C., Radzioch, D., and Ding, A. (1997). Secretory
RPA was performed using the multiprobe assay system RiboQuant leukocyte protease inhibitor: a macrophage product induced by and
(Pharmingen Inc., San Diego, CA) according to the manufacturer’s antagonistic to bacterial lipopolysaccharide. Cell 88, 417–426.
instructions, using total RNA from PMN from septic animals, isolated Li, Q., and Verma, I.M. (2002). NF-kappaB regulation in the immune
as described above. To synthesize anti-sense cRNA, the probes system. Nat. Rev. Immunol. 2, 725–734.
were labeled with 32P-UTP (800 Ci/mmol, 10 mCi/ml; NEN-Dupont,
Matsumoto, T., Yoshida, S., Shiga, Y., Kikuchi, M., Sata, T., andBoston, MA) using a transcription kit according to the manufactur-
Shigematsu, A. (1997). Contribution of neutrophils to lipopolysac-er’s manual. 10 g of each sample was used for hybridization with
charide-induced tumor necrosis factor production and mortality inthe anti-sense RNA probe at 56C for 12–16 hr followed by digestion
a carrageenan-pretreated mouse model. FEMS Immunol. Med. Mi-of free probe and unprotected single stranded RNA with RNase
crobiol. 17, 171–178.solution (RNase A  RNase T1). The remaining double stranded
McDonald, P.P., Bald, A., and Cassatella, M.A. (1997). Activation ofRNA was then extracted in chloroform/isoamyl alcohol (50:1) and
the NF-kappaB pathway by inflammatory stimuli in human neutro-precipitated with ethanol and separated on a 7 M urea/6% polyacryl-
phils. Blood 89, 3421–3433.amide gel. A part of the undigested probe was used as marker
standard. A standard curve plotted with the undigested probe mark- McDonald, P.P., Bovolenta, C., and Cassatella, M.A. (1998). Activa-
ers was used to identify the bands of various genes of interest in tion of distinct transcription factors in neutrophils by bacterial LPS,
the experimental samples. interferon-gamma, and GM-CSF and the necessity to overcome the
action of endogenous proteases. Biochemistry 37, 13165–13173.
Statistical Analysis Nakae, H., Endo, S., Inada, K., Takakuwa, T., Kasai, T., and Yoshida,
All values were expressed as the mean  SEM. Significance was M. (1994). Serum complement levels and severity of sepsis. Res.
assigned where p  0.05. Data sets were analyzed using Students Commun. Chem. Pathol. Pharmacol. 84, 189–195.
t test or using one-way ANOVA, with individual group means being Newcomb, D., Bolgos, G., Green, L., and Remick, D.G. (1998). Antibi-
compared with the Student-Newman-Keuls multiple comparison otic treatment influences outcome in murine sepsis: mediators of
test. increased morbidity. Shock 10, 110–117.
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